Find verified Bremelanotide acetate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Bremelanotide acetate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Bremelanotide acetate API.
Alternate Names: Vyleesi, PT141 acetate
CAS No: 1607799-13-2
PubChem CID: 91971505
Mol Formula: C52H72N14O12
Mol Weight: 1085.2 g/mol
IUPAC Name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-y -Show More
API Description: BREMELANOTIDE ACETATE is a Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for mental or behavioural disorder and sexual dysfunction.
